pubmed-article:14742989 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14742989 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:14742989 | lifeskim:mentions | umls-concept:C0022671 | lld:lifeskim |
pubmed-article:14742989 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:14742989 | lifeskim:mentions | umls-concept:C0010592 | lld:lifeskim |
pubmed-article:14742989 | lifeskim:mentions | umls-concept:C0072980 | lld:lifeskim |
pubmed-article:14742989 | lifeskim:mentions | umls-concept:C0085149 | lld:lifeskim |
pubmed-article:14742989 | lifeskim:mentions | umls-concept:C0035015 | lld:lifeskim |
pubmed-article:14742989 | lifeskim:mentions | umls-concept:C0687133 | lld:lifeskim |
pubmed-article:14742989 | lifeskim:mentions | umls-concept:C0209368 | lld:lifeskim |
pubmed-article:14742989 | lifeskim:mentions | umls-concept:C1882923 | lld:lifeskim |
pubmed-article:14742989 | lifeskim:mentions | umls-concept:C1548437 | lld:lifeskim |
pubmed-article:14742989 | lifeskim:mentions | umls-concept:C0439234 | lld:lifeskim |
pubmed-article:14742989 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
pubmed-article:14742989 | lifeskim:mentions | umls-concept:C0699605 | lld:lifeskim |
pubmed-article:14742989 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:14742989 | pubmed:dateCreated | 2004-1-26 | lld:pubmed |
pubmed-article:14742989 | pubmed:abstractText | To reduce long-term nephrotoxic calcineurin inhibitor dosage, adjunctive sirolimus or mycophenolate mofetil (MMF) was used in a 150-patient, randomized, three-armed trial in cadaveric or human leukocyte antigen non-identical living-donor first renal transplant recipients (n=50/group). | lld:pubmed |
pubmed-article:14742989 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14742989 | pubmed:language | eng | lld:pubmed |
pubmed-article:14742989 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14742989 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14742989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14742989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14742989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14742989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14742989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14742989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14742989 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14742989 | pubmed:month | Jan | lld:pubmed |
pubmed-article:14742989 | pubmed:issn | 0041-1337 | lld:pubmed |
pubmed-article:14742989 | pubmed:author | pubmed-author:RothDavidD | lld:pubmed |
pubmed-article:14742989 | pubmed:author | pubmed-author:BurkeGeorge... | lld:pubmed |
pubmed-article:14742989 | pubmed:author | pubmed-author:RuizPhillipP | lld:pubmed |
pubmed-article:14742989 | pubmed:author | pubmed-author:MillerJoshuaJ | lld:pubmed |
pubmed-article:14742989 | pubmed:author | pubmed-author:CiancioGaetan... | lld:pubmed |
pubmed-article:14742989 | pubmed:author | pubmed-author:KupinWarrenW | lld:pubmed |
pubmed-article:14742989 | pubmed:author | pubmed-author:RosenAnneA | lld:pubmed |
pubmed-article:14742989 | pubmed:author | pubmed-author:MattiazziAdel... | lld:pubmed |
pubmed-article:14742989 | pubmed:author | pubmed-author:GaynorJeffrey... | lld:pubmed |
pubmed-article:14742989 | pubmed:author | pubmed-author:NicolasMaudM | lld:pubmed |
pubmed-article:14742989 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14742989 | pubmed:day | 27 | lld:pubmed |
pubmed-article:14742989 | pubmed:volume | 77 | lld:pubmed |
pubmed-article:14742989 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14742989 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14742989 | pubmed:pagination | 244-51 | lld:pubmed |
pubmed-article:14742989 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:meshHeading | pubmed-meshheading:14742989... | lld:pubmed |
pubmed-article:14742989 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:14742989 | pubmed:articleTitle | A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. | lld:pubmed |
pubmed-article:14742989 | pubmed:affiliation | Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, Florida 33101, USA. gciancio@med.miami.edu | lld:pubmed |
pubmed-article:14742989 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14742989 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:14742989 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:14742989 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:14742989 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14742989 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14742989 | lld:pubmed |